Turnbaugh:Research

From OpenWetWare

(Difference between revisions)
Jump to: navigation, search
Line 4: Line 4:
==Key Questions==
==Key Questions==
-->
-->
-
==Inactivation of cardiac drug by gut microbes==
+
==Inactivation of cardiac drugs by gut microbes==
We are using cell culture, mass spectrometry, and studies in gnotobiotic mice (germ-free and colonized) to determine the mechanism of reduction of digoxin and other cardiac glycosides by members of the gut microbiota, and to determine whether or not it is possible to limit this reaction in vivo.  
We are using cell culture, mass spectrometry, and studies in gnotobiotic mice (germ-free and colonized) to determine the mechanism of reduction of digoxin and other cardiac glycosides by members of the gut microbiota, and to determine whether or not it is possible to limit this reaction in vivo.  
Line 18: Line 18:
See Gordon lab website for previous manuscript supporting information [http://gordonlab.wustl.edu/SuppData.html Supplementary Data]
See Gordon lab website for previous manuscript supporting information [http://gordonlab.wustl.edu/SuppData.html Supplementary Data]
-
==Press==
+
==Selected Press Articles==
[http://www.biotechniques.com/news/Microdroplet-PCR-Takes-on-Population-Genomics/biotechniques-333443.html#.UBqLFo5gP8t Biotechniques piece on microfluidics]
[http://www.biotechniques.com/news/Microdroplet-PCR-Takes-on-Population-Genomics/biotechniques-333443.html#.UBqLFo5gP8t Biotechniques piece on microfluidics]

Revision as of 09:11, 18 October 2012

the turnbaugh lab

home       


Contents

Inactivation of cardiac drugs by gut microbes

We are using cell culture, mass spectrometry, and studies in gnotobiotic mice (germ-free and colonized) to determine the mechanism of reduction of digoxin and other cardiac glycosides by members of the gut microbiota, and to determine whether or not it is possible to limit this reaction in vivo.

Single cell methods for analyzing microbial physiology and gene content

We are using flow cytometry and microfluidics to analyze complex microbial communities collected from the human gut at single cell resolution. These techniques allow us to determine the baseline physiology, activity, and gene content of gut microbes, and how these factors are shaped by clinically relevant perturbations, i.e. exposure to host-targeted drugs and antibiotics.

The role of diet and surgery in shaping the gut microbiome and host metabolic outcomes

We are studying how Roux-en-Y gastric bypass surgery re-shapes the gut microbiota, and to what degree these changes contribute to the metabolic outcomes of surgery (in collaboration with Lee Kaplan group at Mass General Hospital). We are also performing experiments on the role of diet in shaping gut microbial ecology.

Data

Data can be analyzed in MGRAST
Raw datasets are available from GEO and NCBI-SRA
See Gordon lab website for previous manuscript supporting information Supplementary Data

Selected Press Articles

Biotechniques piece on microfluidics

Harvard Gazette write-up on the Turnbaugh lab

Human Microbiome Project

Systems Biology Paper out in PNAS

Science Podcast on detecting novel associations

Wired Microbiome Atlas

Nature News

National Public Radio spot 2009

Economist

Nature video about obesity

New York Times Fat Factors

Nature News 2006

National Public Radio spot 2006

Nature Podcast transcript 2006

Outreach

Exploring Biodiversity Lecture


Personal tools